{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T19:59:59Z","timestamp":1784750399677,"version":"3.55.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jmgm.2021.108106","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T12:48:28Z","timestamp":1639140508000},"page":"108106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Exploring sodium glucose cotransporter (SGLT2) inhibitors with machine learning approach: A novel hope in anti-diabetes drug discovery"],"prefix":"10.1016","volume":"111","author":[{"given":"Md","family":"Moinul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sk Abdul","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhat","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh Kumar","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmita","family":"Gajbhiye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3367-578X","authenticated-orcid":false,"given":"Shovanlal","family":"Gayen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2021.108106_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrneph.2016.170","article-title":"Renal, metabolic and cardiovascular considerations of SGLT2 inhibition","volume":"13","author":"DeFronzo","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jmgm.2021.108106_bib2","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2337\/dc18-0588","article-title":"SGLT2 inhibitors in combination therapy: from mechanisms to clinical considerations in type 2 diabetes management","volume":"41","author":"Van-Baar","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jmgm.2021.108106_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1172\/JCI102424","article-title":"Effect of diabetes and insulin of the maximum capacity of the renal tubules to reabsorb glucose","volume":"30","author":"Farber","year":"1951","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jmgm.2021.108106_bib4","series-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2017"},{"key":"10.1016\/j.jmgm.2021.108106_bib5","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3390\/molecules21091136","article-title":"Sodium-glucose cotransporter 2 (SGLT2) inhibitors from natural products: discovery of next-generation antihyperglycemic agents","volume":"21","author":"Choi","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2021.108106_bib6","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00424-003-1202-0","article-title":"The sodium\/glucose cotransport family SLC5","volume":"447","author":"Wright","year":"2004","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.jmgm.2021.108106_bib7","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1152\/physrev.00055.2009","article-title":"Biology of human sodium glucose transporters","volume":"91","author":"Wright","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jmgm.2021.108106_bib8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1172\/JCI72227","article-title":"Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients","volume":"124","author":"Ferrannini","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jmgm.2021.108106_bib9","doi-asserted-by":"crossref","first-page":"112523","DOI":"10.1016\/j.ejmech.2020.112523","article-title":"An exhaustive perspective on structural insights of SGLT2 inhibitors: a novel class of antidiabetic agent","volume":"204","author":"Bhattacharya","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2021.108106_bib10","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1210\/jc.2011-2260","article-title":"Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin","volume":"97","author":"Bolinder","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.jmgm.2021.108106_bib11","article-title":"The prevalence and risk factors of type 2 diabetes mellitus (DMT2) in a semi-urban Saudi population","volume":"17","author":"Al Mansour","year":"2017","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.jmgm.2021.108106_bib12","doi-asserted-by":"crossref","DOI":"10.2147\/JEP.S226113","article-title":"A recent achievement in the discovery and development of novel targets for the treatment of type-2 diabetes mellitus","volume":"12","author":"Belete","year":"2020","journal-title":"J. Exp. Pharmacol."},{"key":"10.1016\/j.jmgm.2021.108106_bib13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet. Med."},{"key":"10.1016\/j.jmgm.2021.108106_bib14","author":"WHO"},{"key":"10.1016\/j.jmgm.2021.108106_bib15","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/jama.2017.0241","article-title":"Management of type 2 diabetes in 2017","volume":"317","author":"Reusch","year":"2017","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.jmgm.2021.108106_bib16","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0140-6736(06)68341-4","article-title":"Type 1 diabetes","volume":"367","author":"Daneman","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jmgm.2021.108106_bib17","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1038\/nrdp.2015.19","article-title":"Type 2 diabetes mellitus","volume":"1","author":"DeFronzo","year":"2015","journal-title":"Nature Rev. Dis. Primers."},{"key":"10.1016\/j.jmgm.2021.108106_bib18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1021\/acs.oprd.8b00017","article-title":"Synthetic strategies toward sglt2 inhibitors","volume":"22","author":"Aguill\u00f3n","year":"2018","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.jmgm.2021.108106_bib19","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1016\/j.bmcl.2005.08.067","article-title":"Indole-glucosides as novel sodium glucose co-transporter 2 (SGLT2) inhibitors. Part 1","volume":"15","author":"Zhang","year":"2005","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2021.108106_bib20","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.bmcl.2005.12.006","article-title":"Indole-glucosides as novel sodium glucose co-transporter 2 (SGLT2) inhibitors. Part 2","volume":"16","author":"Zhang","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2021.108106_bib21","first-page":"323","article-title":"Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level","author":"Katsuno","year":"2006","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.jmgm.2021.108106_bib22","doi-asserted-by":"crossref","first-page":"6877","DOI":"10.1016\/j.bmcl.2009.10.088","article-title":"Exploration of O-spiroketal C-arylglucosides as novel and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors","volume":"19","author":"Lv","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2021.108106_bib23","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1021\/jm901893x","article-title":"(1S)-1,5-Anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-D-glucitol (TS-071) is a potent, selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for type 2 diabetes treatment","volume":"53","author":"Kakinuma","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2021.108106_bib24","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/cmdc.201000051","article-title":"Conformationally constrained spiro C-arylglucosides as potent and selective renal sodium-dependent glucose Co-transporter 2 (SGLT2) inhibitors","volume":"5","author":"Lv","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jmgm.2021.108106_bib25","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1021\/jm100332n","article-title":"Discovery of canagliflozin, a novel C-glucoside with thiophene ring, as sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes mellitus","volume":"5","author":"Nomura","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2021.108106_bib26","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1016\/j.bmc.2010.04.088","article-title":"Ortho-Substituted C-aryl glucosides as highly potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors","volume":"18","author":"Xu","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jmgm.2021.108106_bib27","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1016\/j.bmcl.2010.09.103","article-title":"Pyrimidinylmethylphenyl glucoside as novel C-aryl glucoside SGLT2 inhibitors","volume":"20","author":"Lee","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2021.108106_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1021\/ml900010b","article-title":"Synthesis and SAR of benzisothiazole- and indolizine-\u03b2-D-glucopyranoside inhibitors of SGLT2","volume":"1","author":"Zhou","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jmgm.2021.108106_bib29","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1016\/j.bmcl.2011.06.032","article-title":"C-Aryl glucosides substituted at the 4\u2019 -position as potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors for the treatment of type 2","volume":"21","author":"Xu","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2021.108106_bib30","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1021\/jm200049r","article-title":"Discovery of a clinical candidate from the structurally unique dioxa-bicyclo[3.2.1]octane class of sodium-dependent glucose cotransporter 2 inhibitors","volume":"54","author":"Mascitti","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2021.108106_bib31","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.bmcl.2010.11.115","article-title":"Exploration of SAR regarding glucose moiety in novel C-aryl glucoside inhibitors of SGLT2","volume":"21","author":"Park","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2021.108106_bib32","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1016\/j.bmcl.2011.04.063","article-title":"Glucosides with cyclic diarylpolynoid as novel C-aryl glucoside SGLT2 inhibitors","volume":"21","author":"Kang","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2021.108106_bib33","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1016\/j.bmc.2011.07.045","article-title":"Novel macrocyclic C-aryl glucoside SGLT2 inhibitors as potential anti-diabetic agents","volume":"19","author":"Kim","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jmgm.2021.108106_bib34","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1016\/j.bmc.2011.08.014","article-title":"Novel thiophenyl C-aryl glucoside SGLT2 inhibitors as potential antidiabetic agents","volume":"19","author":"Lee","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jmgm.2021.108106_bib35","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1016\/j.bmc.2013.05.048","article-title":"C-Glucosides with heteroaryl thiophene as novel sodium-dependent glucose cotransporter 2 inhibitors","volume":"21","author":"Koga","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jmgm.2021.108106_bib36","article-title":"Synthesis of Tofogliflozin as an SGLT2 inhibitor via construction of dihydroisobenzofuran by intramolecular [4 + 2] cycloaddition","author":"Murakata","year":"2018","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.jmgm.2021.108106_bib37","series-title":"Object Classification Method","first-page":"80","author":"Du","year":"2008"},{"key":"10.1016\/j.jmgm.2021.108106_bib38","series-title":"Statistical Decision Theory and Bayesian Analysis","author":"Berger","year":"2013"},{"key":"10.1016\/j.jmgm.2021.108106_bib39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/10629360290002280","article-title":"Bayesian analysis and inference from QSAR predictive model results","volume":"13","author":"Mcdowella","year":"2002","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.jmgm.2021.108106_bib40","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.4155\/fmc-2018-0005","article-title":"Diverse classes of HDAC8 inhibitors: in search of molecular fingerprints that regulate activity","volume":"10","author":"Amin","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.jmgm.2021.108106_bib41","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1039\/C9NJ05825G","article-title":"In silico modelling, identification of crucial molecular fingerprint, and prediction of the new possible substrates of human organic cationic transporters 1 and 2","volume":"44","author":"Baidya","year":"2020","journal-title":"New J. Chem."},{"key":"10.1016\/j.jmgm.2021.108106_bib42","first-page":"66","article-title":"Good and bad molecular fingerprints for human rhinovirus 3C protease inhibition: identification, validation, and application in designing of new inhibitors through Monte Carlo-based QSAR study","volume":"30","author":"Jain","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2021.108106_bib43","series-title":"Discovery Studio 3.0 (DS 3.0)","year":"2015"},{"key":"10.1016\/j.jmgm.2021.108106_bib44","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.patrec.2005.10.010","article-title":"An introduction to ROC analysis","volume":"27","author":"Fawcett","year":"2006","journal-title":"Pattern Recogn. Lett."},{"key":"10.1016\/j.jmgm.2021.108106_bib45","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/mp100465q","article-title":"ADME evaluation in drug discovery. 10. Predictions of P-glycoprotein inhibitors using recursive partitioning and Naive Bayesian classification techniques","volume":"8","author":"Chen","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jmgm.2021.108106_bib46","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1198\/106186008X319331","article-title":"Model-based recursive partitioning","volume":"17","author":"Zeileis","year":"2008","journal-title":"J. Comput. Graph Stat."},{"key":"10.1016\/j.jmgm.2021.108106_bib47","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1021\/ci100050t","article-title":"Extended-connectivity fingerprints","volume":"50","author":"David","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2021.108106_bib48","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.1021\/acs.jmedchem.0c01077","article-title":"Artificial intelligence in drug discovery: into the great wide open","volume":"63","author":"Bajorath","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2021.108106_bib49","first-page":"1","article-title":"The machine learning life cycle and the cloud: implications for drug discovery","volume":"31","author":"Spjuth","year":"2021","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.jmgm.2021.108106_bib50","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.3390\/ijms22094435","article-title":"Deep learning in virtual screening: recent applications and developments","volume":"22","author":"Kimber","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmgm.2021.108106_bib51","unstructured":"Supervised learning \u2014 scikit-learn 0.23.2 documentation.\u201d Available: https:\/\/scikit-learn.org\/stable\/supervised_learning.html#supervised-learning. [Accessed: 31-Aug-2020].."},{"key":"10.1016\/j.jmgm.2021.108106_bib52","unstructured":"sklearn.linear_model.LogisticRegression \u2014 scikit-learn 0.23.2 documentation.\u201d Available: https:\/\/scikit-learn.org\/stable\/modules\/generated\/sklearn.linear_model.LogisticRegression.html. [Accessed: 31-Aug-2020].."},{"key":"10.1016\/j.jmgm.2021.108106_bib53","unstructured":"sklearn.neighbors.KNeighborsClassifier \u2014 scikit-learn 0.23.2 documentation.\u201d [Online]. Available: https:\/\/scikit-learn.org\/stable\/modules\/generated\/sklearn.neighbors.KNeighborsClassifier.html. [Accessed: 31-Aug-2020].."},{"key":"10.1016\/j.jmgm.2021.108106_bib54","unstructured":"sklearn.svm.SVC \u2014 scikit-learn 0.23.2 documentation.\u201d Available: https:\/\/scikit-learn.org\/stable\/modules\/generated\/sklearn.svm.SVC.html. [Accessed: 31-Aug-2020].."},{"key":"10.1016\/j.jmgm.2021.108106_bib55","unstructured":"sklearn.tree.DecisionTreeClassifier \u2014 scikit-learn 0.23.2 documentation.\u201d Available: https:\/\/scikit-learn.org\/stable\/modules\/generated\/sklearn.tree.DecisionTreeClassifier.html. [Accessed: 31-Aug-2020].."},{"key":"10.1016\/j.jmgm.2021.108106_bib56","unstructured":"sklearn.ensemble.RandomForestClassifier \u2014 scikit-learn 0.23.2 documentation.\u201d Available: https:\/\/scikit-learn.org\/stable\/modules\/generated\/sklearn.ensemble.RandomForestClassifier.html. [Accessed: 31-Aug-2020].."},{"key":"10.1016\/j.jmgm.2021.108106_bib57","unstructured":"sklearn.ensemble.AdaBoostClassifier \u2014 scikit-learn 0.23.2 documentation.\u201d [Online]. Available: https:\/\/scikit-learn.org\/stable\/modules\/generated\/sklearn.ensemble.AdaBoostClassifier.html. [Accessed: 31-Aug-2020].."},{"key":"10.1016\/j.jmgm.2021.108106_bib58","unstructured":"sklearn.ensemble.GradientBoostingClassifier \u2014 scikit-learn 0.24.1 documentation.\u201d [Online]. Available: https:\/\/scikit-learn.org\/stable\/modules\/generated\/sklearn.ensemble.GradientBoostingClassifier.html. [Accessed: 16-Mar-2021]."},{"key":"10.1016\/j.jmgm.2021.108106_bib59","unstructured":"sklearn.naive_bayes.GaussianNB \u2014 scikit-learn 0.23.2 documentation.\u201d [Online]. Available: https:\/\/scikit-learn.org\/stable\/modules\/generated\/sklearn.naive_bayes.GaussianNB.html. [Accessed: 31-Aug-2020].."},{"key":"10.1016\/j.jmgm.2021.108106_bib60","unstructured":"sklearn.discriminant_analysis.LinearDiscriminantAnalysis \u2014 scikit-learn 0.23.2 documentation.\u201d [Online]. Available: https:\/\/scikit-learn.org\/stable\/modules\/generated\/sklearn.discriminant_analysis.LinearDiscriminantAnalysis.html. [Accessed: 31-Aug-2020].."},{"key":"10.1016\/j.jmgm.2021.108106_bib61","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","article-title":"Receiver operating characteristic curve in diagnostic test assessment","volume":"5","author":"Mandrekar","year":"2010","journal-title":"J. Thorac. Oncol."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326321002771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326321002771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:10:05Z","timestamp":1761081005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326321002771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":61,"alternative-id":["S1093326321002771"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2021.108106","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring sodium glucose cotransporter (SGLT2) inhibitors with machine learning approach: A novel hope in anti-diabetes drug discovery","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2021.108106","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108106"}}